Companies: 10,795·Total market cap: $144.5T
Mustang Bio, Inc.

Mustang Bio, Inc.

MBIONASDAQHealthcare● Active
$0.70
+$0.03(+4.49%)
Market Cap$5305011
P/E Ratio
52W High$7
52W Low$0.531
Overview

Mustang Bio, Inc. (MBIO) Revenue

Annual & quarterly revenue history · segment & region breakdown

MBIO · revenue · updated Jun 9, 2026

Core revenue metrics

Mustang Bio, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
mktCap ÷ TTM rev
Revenue per day
Est. TTM ÷ 365
Revenue / employee
$0K
6 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Mustang Bio, Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
MBIO revenue by year · MBIO revenue history · MBIO annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Mustang Bio, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Mustang Bio, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Mustang Bio, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

MBIO revenue · 4 questions

MBIO's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

MBIO revenueMBIO annual revenuewhat is MBIO revenueMBIO TTM revenue

Source: FMP · Mustang Bio, Inc. SEC filings · GAAP · Mustang Bio, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026